Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36 | -$27 | -$37 | -$21 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $3 | $3 |
| Change in WC | $3 | -$2 | $5 | -$12 |
| Other Non-Cash | $4 | $0 | $0 | -$0 |
| Operating Cash Flow | -$29 | -$26 | -$28 | -$30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$236 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$236 | $0 | $0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$265 | -$25 | -$28 | -$31 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $437 | $462 | $490 | $521 |
| End Cash | $172 | $437 | $462 | $490 |
| Free Cash Flow | -$29 | -$26 | -$28 | -$30 |